MedTech Europe: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedTech Europe
Largest movements
- Cash +€1.3m
up €1.3m (+19.1%), from €6.9m to €8.2m
mainly Current investments (+€998,407) and Provisions (+€850,000)
- Current investments -€998,407
down €998,407 (-28.4%), from €3.5m to €2.5m
- Receivables within one year -€568,320
down €568,320 (-36.7%), from €1.5m to €979,147
of which Trade receivables: -€814,909
- Debts within one year -€896,395
down €896,395 (-28.9%), from €3.1m to €2.2m
of which Tax, wage and social debts: -€812,198
- Provisions +€850,000
new in 2023: €850,000
- Accrued charges and deferred income -€209,215
down €209,215 (-33.9%), from €617,691 to €408,476
- Staff costs -€650,471
down €650,471 (-9.2%), from €7.1m to €6.4m
- Services and other goods +€173,107
up €173,107 (+3.7%), from €4.6m to €4.8m
From the 2022 result to the 2023 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2022 and 2023 balance sheets and the 2023 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2022 | 2023 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,163,398 | €11,921,645 | -€241,753 | -2.0% |
| Fixed assets | 21/28 | €239,285 | €173,833 | -€65,451 | -27.4% |
| Tangible fixed assets | 22/27 | €239,285 | €173,833 | -€65,451 | -27.4% |
| Plant, machinery and equipment | 23 | €208,061 | €144,136 | -€63,925 | -30.7% |
| Furniture and vehicles | 24 | €31,224 | €29,697 | -€1,526 | -4.9% |
| Current assets | 29/58 | €11,924,113 | €11,747,812 | -€176,301 | -1.5% |
| Amounts receivable within one year | 40/41 | €1,547,467 | €979,147 | -€568,320 | -36.7% |
| Trade receivables | 40 | €1,414,841 | €599,931 | -€814,909 | -57.6% |
| Other amounts receivable | 41 | €132,626 | €379,216 | +€246,590 | +186% |
| Current investments | 50/53 | €3,512,243 | €2,513,836 | -€998,407 | -28.4% |
| Cash at bank and in hand | 54/58 | €6,857,761 | €8,167,144 | +€1.3m | +19.1% |
| Deferred charges and accrued income | 490/1 | €6,642 | €87,684 | +€81,042 | +1,220% |
| Total equity and liabilities | 10/49 | €12,163,398 | €11,921,645 | -€241,753 | -2.0% |
| Equity | 10/15 | €8,445,130 | €8,458,988 | +€13,858 | +0.2% |
| Contributions | 10/11 | €5,433 | €5,433 | = | 0.0% |
| Capital | 10 | €5,433 | €5,433 | = | 0.0% |
| Reserves | 13 | €6,536,687 | €6,536,687 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,903,010 | €1,916,868 | +€13,858 | +0.7% |
| Provisions and deferred taxes | 16 | - | €850,000 | +€850,000 | |
| Provisions for liabilities and charges | 160/5 | - | €850,000 | +€850,000 | |
| Other liabilities and charges | 164/5 | - | €850,000 | +€850,000 | |
| Amounts payable | 17/49 | €3,718,268 | €2,612,657 | -€1.1m | -29.7% |
| Amounts payable within one year | 42/48 | €3,100,576 | €2,204,181 | -€896,395 | -28.9% |
| Trade debts | 44 | €884,965 | €915,405 | +€30,440 | +3.4% |
| Suppliers | 440/4 | €884,965 | €915,405 | +€30,440 | +3.4% |
| Taxes, remuneration and social security | 45 | €2,092,137 | €1,279,939 | -€812,198 | -38.8% |
| Taxes | 450/3 | €556,772 | €64 | -€556,707 | -100.0% |
| Remuneration and social security | 454/9 | €1,535,365 | €1,279,875 | -€255,490 | -16.6% |
| Accrued charges and deferred income | 492/3 | €617,691 | €408,476 | -€209,215 | -33.9% |
| Operating income | 70/76A | €11,878,756 | €12,348,053 | +€469,298 | +4.0% |
| Membership fees, donations, legacies and grants | 73 | €11,579,390 | €12,029,374 | +€449,984 | +3.9% |
| Other operating income | 74 | €299,366 | €318,680 | +€19,314 | +6.5% |
| Operating charges | 60/66A | €11,850,658 | €12,301,406 | +€450,748 | +3.8% |
| Services and other goods | 61 | €4,617,241 | €4,790,348 | +€173,107 | +3.7% |
| Remuneration, social security and pensions | 62 | €7,085,356 | €6,434,885 | -€650,471 | -9.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €103,157 | €98,645 | -€4,513 | -4.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €40,231 | €122,752 | +€82,522 | +205% |
| Other operating charges | 640/8 | €4,673 | €4,777 | +€104 | +2.2% |
| Operating profit (loss) | 9901 | €28,098 | €46,647 | +€18,550 | +66.0% |
| Financial income | 75/76B | €3,426 | €4,881 | +€1,456 | +42.5% |
| Recurring financial income | 75 | €3,426 | €4,881 | +€1,456 | +42.5% |
| Income from current assets | 751 | €743 | €3,551 | +€2,809 | +378% |
| Other financial income | 752/9 | €2,683 | €1,330 | -€1,353 | -50.4% |
| Financial charges | 65/66B | €10,653 | €30,794 | +€20,141 | +189% |
| Recurring financial charges | 65 | €10,653 | €30,794 | +€20,141 | +189% |
| Debt charges | 650 | - | €77 | +€77 | |
| Other financial charges | 652/9 | €10,653 | €30,716 | +€20,064 | +188% |
| Profit (loss) for the period before taxes | 9903 | €20,870 | €20,735 | -€135 | -0.6% |
| Income taxes | 67/77 | €4,473 | €6,877 | +€2,404 | +53.7% |
| Taxes | 670/3 | €4,473 | €6,877 | +€2,404 | +53.7% |
| Profit (loss) for the period | 9904 | €16,398 | €13,858 | -€2,540 | -15.5% |
| Profit (loss) for the period to be appropriated | 9905 | €16,398 | €13,858 | -€2,540 | -15.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2022 and 31 December 2023. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.